MPE would like to thank the following organisations and stakeholders for their support, contributions and advice provided to creating the Myeloma Access Atlas (in alphabetical order).


  • Amgen
  • AstraZeneca
  • AR Difusion
  • Avedis Donabedian Research Institute
  • Bristol Myers Squibb
  • Eric Low Consulting
  • GSK
  • Janssen
  • Karyopharm
  • Mundipharma
  • Novartis
  • Oncopeptides
  • Patvocates
  • Pfizer
  • Roche
  • Sanofi
  • Takeda

MPE would like to extend a special thank you to the pharmaceutical companies that routinely provide us with the data used to populate the Atlas. We’d like to specifically highlight and acknowledge the vital in-kind support Pfizer has provided us via strategic partnership with IQVIA.

MPE would also like to extend a huge thank-you to our members and myeloma doctors who continue to review and provide data to the Atlas.